A 4-week-old male infant is brought to the pediatric clinic for evaluation of poor feeding and lethargy. The parents report vomiting and weight loss. Laboratory results show hyponatremia (Na+ 128 mEq/L) and hyperkalemia (K+ 6.2 mEq/L). Which assessment finding would be most indicative of congenital adrenal hyperplasia (CAH)?

Elevated 17-hydroxyprogesterone is the most specific diagnostic finding for CAH, reflecting enzyme deficiency. Other options are not indicative of CAH in this context.

Understanding the Clinical Presentation

The infant in this scenario presents with a classic triad of poor feeding, lethargy, and vomiting, accompanied by significant laboratory abnormalities: hyponatremia (Na+ 128 mEq/L) and hyperkalemia (K+ 6.2 mEq/L). This electrolyte pattern is the hallmark of a salt-wasting crisis, a life-threatening manifestation of adrenal insufficiency. In the context of a 4-week-old infant, the primary condition that must be ruled out is Congenital Adrenal Hyperplasia (CAH).

The Pathophysiology of CAH and the Rationale for the Correct Answer

CAH is a group of autosomal recessive disorders caused by defects in enzymes responsible for cortisol synthesis in the adrenal cortex ^[3]. The most common form is 21-hydroxylase deficiency. This enzymatic block prevents the effective production of cortisol and, in the salt-wasting form, aldosterone. The lack of cortisol removes the negative feedback loop on the pituitary gland, leading to an overproduction of adrenocorticotropic hormone (ACTH). ACTH relentlessly stimulates the adrenal cortex, causing hyperplasia and a buildup of steroid precursors upstream of the blocked enzyme. The key precursor that accumulates in 21-hydroxylase deficiency is 17-hydroxyprogesterone (17-OHP).

Therefore, an elevated 17-OHP level is the most specific biochemical marker for the most common form of CAH and is the cornerstone of diagnosis. This is why newborn screening programs, as highlighted in the literature, measure 17-OHP levels to detect affected infants before a life-threatening crisis occurs ^[4]. The case of the infant presenting with sudden cardiac arrest due to an adrenal crisis from a rarer enzyme deficiency, 3β-hydroxysteroid dehydrogenase (3β-HSD2) deficiency, also underscores the critical nature of identifying CAH, even though the specific steroid profile would differ ^[1]. The principle remains that a salt-wasting crisis in a young infant points directly to an inborn error of adrenal steroidogenesis until proven otherwise.

Analysis of Incorrect Options

Option 2: Decreased cortisol levels only. While cortisol is indeed low in CAH, this finding is not specific. An isolated low cortisol level could be due to a variety of other conditions, including primary adrenal insufficiency from other causes, secondary adrenal insufficiency due to pituitary dysfunction, or even a lab artifact. Furthermore, the diagnosis of CAH hinges on demonstrating the accumulation of precursor hormones (like 17-OHP) that occurs as a consequence of the enzyme block, not just the deficiency of the end-product. In a salt-wasting crisis, the more immediately life-threatening issue is the mineralocorticoid deficiency leading to the electrolyte imbalance.

Option 3: Elevated growth hormone levels. Growth hormone is produced by the anterior pituitary and is not directly involved in the adrenal steroidogenesis pathway. CAH is a defect confined to the adrenal cortex's enzymatic machinery for producing cortisol, aldosterone, and androgens ^[3]. There is no pathophysiological link between an enzyme deficiency in the adrenal gland and a primary elevation in growth hormone.

Option 4: Decreased thyroid-stimulating hormone levels. TSH is a pituitary hormone that regulates the thyroid gland and is entirely separate from the hypothalamic-pituitary-adrenal (HPA) axis. CAH does not directly cause a decrease in TSH. While critically ill infants can sometimes exhibit alterations in thyroid function tests as part of a non-thyroidal illness syndrome, a decreased TSH is not a diagnostic indicator for CAH.

Clinical and Diagnostic Correlation

The urgency in this clinical picture cannot be overstated. The case report of an infant with a delayed presentation of salt-wasting CAH who experienced a sudden cardiac arrest serves as a stark reminder that these patients can deteriorate rapidly ^[1]. The initial well-being of an infant does not rule out CAH, as decompensation can be triggered by the stress of an illness or progressively worsen over the first few weeks of life. The report of four consecutive false-negative newborn screens in a patient with classical CAH further complicates the picture, emphasizing that clinical suspicion must override a negative screening test when symptoms are present ^[4]. In such cases, the definitive diagnostic step is to measure serum 17-OHP, which will be markedly elevated, confirming the diagnosis and allowing for the immediate initiation of life-saving glucocorticoid and mineralocorticoid replacement therapy. Advanced techniques like liquid chromatography-tandem mass spectrometry (LC-MS/MS) can provide a more comprehensive steroid profile to differentiate between various forms of CAH, but the initial critical finding is the elevated 17-OHP ^[3].